MyAverix Finance MyAverix Finance

VN · Healthcare

Central Pharmaceutical JSC No3 (DP3)

Pharmaceuticals

Central Pharmaceutical JSC No3 (DP3) is listed on VN in the Healthcare sector. Industry: Pharmaceuticals. As of 2026-05-21, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-05-21

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for DP3

P/E ratio
18.00

Central Pharmaceutical JSC No3 (DP3) — FAQ

What is DP3's P/E ratio?

The price-to-earnings (P/E) ratio for Central Pharmaceutical JSC No3 (DP3) is 18.00 (data as of 2026-05-21).

Does Central Pharmaceutical JSC No3 pay a dividend?

Dividend yield is not available in the current snapshot for Central Pharmaceutical JSC No3 (DP3). Check the MyAverix Finance app for the latest dividend data.

What sector is Central Pharmaceutical JSC No3 in?

Central Pharmaceutical JSC No3 (DP3) is classified in the Healthcare sector (Pharmaceuticals industry).

What exchange is DP3 listed on?

DP3 is listed on VN.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play